373 related articles for article (PubMed ID: 22802087)
1. Novel presentations of congenital hyperinsulinism due to mutations in the MODY genes: HNF1A and HNF4A.
Stanescu DE; Hughes N; Kaplan B; Stanley CA; De León DD
J Clin Endocrinol Metab; 2012 Oct; 97(10):E2026-30. PubMed ID: 22802087
[TBL] [Abstract][Full Text] [Related]
2. Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene.
Pearson ER; Boj SF; Steele AM; Barrett T; Stals K; Shield JP; Ellard S; Ferrer J; Hattersley AT
PLoS Med; 2007 Apr; 4(4):e118. PubMed ID: 17407387
[TBL] [Abstract][Full Text] [Related]
3. Double heterozygous mutations involving both HNF1A/MODY3 and HNF4A/MODY1 genes: a case report.
Forlani G; Zucchini S; Di Rocco A; Di Luzio R; Scipione M; Marasco E; Romeo G; Marchesini G; Mantovani V
Diabetes Care; 2010 Nov; 33(11):2336-8. PubMed ID: 20705777
[TBL] [Abstract][Full Text] [Related]
4. Clinical heterogeneity of hyperinsulinism due to HNF1A and HNF4A mutations.
Tung JY; Boodhansingh K; Stanley CA; De León DD
Pediatr Diabetes; 2018 Aug; 19(5):910-916. PubMed ID: 29493090
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia.
Colclough K; Bellanne-Chantelot C; Saint-Martin C; Flanagan SE; Ellard S
Hum Mutat; 2013 May; 34(5):669-85. PubMed ID: 23348805
[TBL] [Abstract][Full Text] [Related]
6. Diazoxide-responsive hyperinsulinemic hypoglycemia caused by HNF4A gene mutations.
Flanagan SE; Kapoor RR; Mali G; Cody D; Murphy N; Schwahn B; Siahanidou T; Banerjee I; Akcay T; Rubio-Cabezas O; Shield JP; Hussain K; Ellard S
Eur J Endocrinol; 2010 May; 162(5):987-92. PubMed ID: 20164212
[TBL] [Abstract][Full Text] [Related]
7. Clinical and genetic heterogeneity of HNF4A/HNF1A mutations in a multicentre paediatric cohort with hyperinsulinaemic hypoglycaemia.
McGlacken-Byrne SM; Mohammad JK; Conlon N; Gubaeva D; Siersbæk J; Schou AJ; Demirbilek H; Dastamani A; Houghton JAL; Brusgaard K; Melikyan M; Christesen H; Flanagan SE; Murphy NP; Shah P
Eur J Endocrinol; 2022 Feb; 186(4):417-427. PubMed ID: 35089870
[TBL] [Abstract][Full Text] [Related]
8. Persistent hyperinsulinemic hypoglycemia and maturity-onset diabetes of the young due to heterozygous HNF4A mutations.
Kapoor RR; Locke J; Colclough K; Wales J; Conn JJ; Hattersley AT; Ellard S; Hussain K
Diabetes; 2008 Jun; 57(6):1659-63. PubMed ID: 18268044
[TBL] [Abstract][Full Text] [Related]
9. Congenital hyperinsulinism due to mutations in HNF1A.
Yau D; Colclough K; Natarajan A; Parikh R; Canham N; Didi M; Senniappan S; Banerjee I
Eur J Med Genet; 2020 Jun; 63(6):103928. PubMed ID: 32325224
[TBL] [Abstract][Full Text] [Related]
10. A Novel
Chandran S; Rajadurai VS; Hoi WH; Flanagan SE; Hussain K; Yap F
Front Pediatr; 2020; 8():320. PubMed ID: 32670997
[TBL] [Abstract][Full Text] [Related]
11. Screening of HNF1A and HNF4A mutation and clinical phenotype analysis in a large cohort of Chinese patients with maturity-onset diabetes of the young.
Wang X; Wang T; Yu M; Zhang H; Ping F; Zhang Q; Xu J; Feng K; Xiao X
Acta Diabetol; 2019 Mar; 56(3):281-288. PubMed ID: 30293189
[TBL] [Abstract][Full Text] [Related]
12. Congenital hyperinsulinism and glycogenosis-like phenotype due to a novel HNF4A mutation.
Stanik J; Skopkova M; Brennerova K; Danis D; Rosolankova M; Salingova A; Bzduch V; Klimes I; Gasperikova D
Diabetes Res Clin Pract; 2017 Apr; 126():144-150. PubMed ID: 28242437
[TBL] [Abstract][Full Text] [Related]
13. Identification of HNF1A-MODY and HNF4A-MODY in Irish families: phenotypic characteristics and therapeutic implications.
Kyithar MP; Bacon S; Pannu KK; Rizvi SR; Colclough K; Ellard S; Byrne MM
Diabetes Metab; 2011 Dec; 37(6):512-9. PubMed ID: 21683639
[TBL] [Abstract][Full Text] [Related]
14. The evolving course of HNF4A hyperinsulinaemic hypoglycaemia--a case series.
McGlacken-Byrne SM; Hawkes CP; Flanagan SE; Ellard S; McDonnell CM; Murphy NP
Diabet Med; 2014 Jan; 31(1):e1-5. PubMed ID: 23796040
[TBL] [Abstract][Full Text] [Related]
15. Digenic heterozygous HNF1A and HNF4A mutations in two siblings with childhood-onset diabetes.
Shankar RK; Ellard S; Standiford D; Pihoker C; Gilliam LK; Hattersley A; Dolan LM
Pediatr Diabetes; 2013 Nov; 14(7):535-8. PubMed ID: 23551881
[TBL] [Abstract][Full Text] [Related]
16. High Incidence of Heterozygous ABCC8 and HNF1A Mutations in Czech Patients With Congenital Hyperinsulinism.
Rozenkova K; Malikova J; Nessa A; Dusatkova L; Bjørkhaug L; Obermannova B; Dusatkova P; Kytnarova J; Aukrust I; Najmi LA; Rypackova B; Sumnik Z; Lebl J; Njølstad PR; Hussain K; Pruhova S
J Clin Endocrinol Metab; 2015 Dec; 100(12):E1540-9. PubMed ID: 26431509
[TBL] [Abstract][Full Text] [Related]
17. Characterization of beta cell and incretin function in patients with MODY1 (HNF4A MODY) and MODY3 (HNF1A MODY) in a Swedish patient collection.
Ekholm E; Shaat N; Holst JJ
Acta Diabetol; 2012 Oct; 49(5):349-54. PubMed ID: 21761282
[TBL] [Abstract][Full Text] [Related]
18. Clinical and laboratory clues of maturity-onset diabetes of the young and determination of association with molecular diagnosis.
Karaoglan M; Nacarkahya G
J Diabetes; 2021 Feb; 13(2):154-163. PubMed ID: 32710514
[TBL] [Abstract][Full Text] [Related]
19. Detection of hepatocyte nuclear factor 4A(
Vlachopapadopoulou EA; Dikaiakou E; Fotiadou A; Sifianou P; Tatsi EB; Sertedaki A; Kanaka-Gantenbein C; Michalacos S
J Pediatr Endocrinol Metab; 2021 Apr; 34(4):527-530. PubMed ID: 33031054
[TBL] [Abstract][Full Text] [Related]
20. The spectrum of HNF1A gene mutations in Greek patients with MODY3: relative frequency and identification of seven novel germline mutations.
Tatsi C; Kanaka-Gantenbein C; Vazeou-Gerassimidi A; Chrysis D; Delis D; Tentolouris N; Dacou-Voutetakis C; Chrousos GP; Sertedaki A
Pediatr Diabetes; 2013 Nov; 14(7):526-34. PubMed ID: 23517481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
